Semi-Annual Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7730500

Concept 2017-06-01 to
2017-11-30
2016-06-01 to
2016-11-30
Semi-annual statement of income
Statement of income
Net sales
20,454,187,000 JPY
19,219,449,000 JPY
Cost of sales
16,223,145,000 JPY
15,147,928,000 JPY
Ordinary profit (loss)
2,304,443,000 JPY
2,083,300,000 JPY
Gross profit (loss)
4,231,042,000 JPY
4,071,521,000 JPY
Extraordinary income
20,524,000 JPY
8,700,000 JPY
Selling, general and administrative expenses
1,967,677,000 JPY
1,947,365,000 JPY
Extraordinary losses
292,000 JPY
7,078,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
2,265,504,000 JPY
2,126,320,000 JPY
Profit (loss) before income taxes
2,324,676,000 JPY
2,084,922,000 JPY
Non-operating income
63,095,000 JPY
65,844,000 JPY
Non-operating income
Interest income
2,143,000 JPY
468,000 JPY
Dividend income
38,573,000 JPY
40,667,000 JPY
Non-operating expenses
24,156,000 JPY
108,865,000 JPY
Income taxes
752,628,000 JPY
675,933,000 JPY
Profit (loss)
1,572,047,000 JPY
1,408,988,000 JPY
Non-operating expenses
Interest expenses
13,892,000 JPY
15,022,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.